Dare Bioscience, Inc. has amended its Third Amended and Restated By-Laws to change the voting requirements for its annual and special meetings of stockholders. The amendment, approved by the company's board of directors on September 10, 2026, is effective immediately.
Previously, a majority in voting power of the issued and outstanding shares of the company's capital stock was required to constitute a quorum at any meeting. Under the new amendment, a quorum is now defined as the holders of at least one-third of the voting power of the issued and outstanding shares of the company's capital stock entitled to vote at the meeting.
The filing indicates that the amendment was made to facilitate the holding of meetings in a virtual format. The text of the amendment is attached as Exhibit 3.1 to the report.
